Squamous Cell Non-small Cell Lung Cancer Recruiting Phase 2 Trials for Endostatin (DB06423)

Also known as: Squamous Cell Carcinoma, Non-Small-Cell Lung / Lung Non-Small Cell Squamous Carcinoma / Non-Small Cell Squamous Lung Carcinoma / Non-Small Cell Squamous Lung Cancer / Squamous Non-Small Cell Lung Cancer (sqNSCLC) / Squamous NSCLC / Squamous Non-Small Cell Lung Cancer / Squamous cell cancer Non-small cell lung cancer / Squamous non-small cell lung cancer (disorder) / Epidermoid carcinoma lung / Squamous cell carcinoma of lung stage unspecified / Lung squamous cell carcinoma stage unspecified / Squamous cell carcinoma of lung (disorder) / Squamous cell carcinoma of lung

IndicationStatusPhase
DBCOND0059210 (Squamous Cell Non-small Cell Lung Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05243355Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLCTreatment